Find Pirenoxine Sodium manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 51410-30-1, Catalin sodium, Pirenoxine sodium salt, Sodium 1-hydroxy-5-oxo-5h-pyrido[3,2-a]phenoxazine-3-carboxylate, 95ju7urf64, Sodium;1,5-dioxo-4h-pyrido[3,2-a]phenoxazine-3-carboxylate
Molecular Formula
C16H7N2NaO5
Molecular Weight
330.23  g/mol
InChI Key
HDQXPMXHXZNPKE-UHFFFAOYSA-M
FDA UNII
95JU7URF64

Pirenoxine Sodium
1 2D Structure

Pirenoxine Sodium

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
sodium;1,5-dioxo-4H-pyrido[3,2-a]phenoxazine-3-carboxylate
2.1.2 InChI
InChI=1S/C16H8N2O5.Na/c19-9-5-8(16(21)22)18-14-10(20)6-12-15(13(9)14)17-7-3-1-2-4-11(7)23-12;/h1-6H,(H,18,19)(H,21,22);/q;+1/p-1
2.1.3 InChI Key
HDQXPMXHXZNPKE-UHFFFAOYSA-M
2.1.4 Canonical SMILES
C1=CC=C2C(=C1)N=C3C(=CC(=O)C4=C3C(=O)C=C(N4)C(=O)[O-])O2.[Na+]
2.2 Other Identifiers
2.2.1 UNII
95JU7URF64
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 51410-30-1

2. Catalin Sodium

3. Pirenoxine Sodium Salt

4. Sodium 1-hydroxy-5-oxo-5h-pyrido[3,2-a]phenoxazine-3-carboxylate

5. 95ju7urf64

6. Sodium;1,5-dioxo-4h-pyrido[3,2-a]phenoxazine-3-carboxylate

7. 5h-pyrido(3,2-a)phenoxazine-3-carboxylic Acid, 1-hydroxy-5-oxo-, Monosodium Salt

8. Sodium 1-hydroxy-5-oxo-5h-pyrido(3,2-a)phenoxazine-3-carboxylate

9. Clarvisan (tn)

10. Ncgc00167452-01

11. Einecs 257-181-6

12. Unii-95ju7urf64

13. Pirfenoxone Sodium

14. 1-hydroxy-5-oxo-5h-pyrido(3,2-a)phenoxazine-3-carboxylic Acid Sodium Salt

15. Dsstox_cid_26637

16. Dsstox_rid_81783

17. Dsstox_gsid_46637

18. Pirfenoxone Sodium Salt

19. Schembl1650064

20. Chembl2359957

21. Dtxsid1046637

22. Schembl11579562

23. Pirenoxine Sodium [mart.]

24. Pirenoxine Sodium [who-dd]

25. Bcp12124

26. Pirenoxine Sodium Salt [mi]

27. Tox21_112456

28. Akos015951393

29. Cas-51410-30-1

30. D08388

31. W-105897

32. Q27271800

33. (5-methyl-2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methanol

34. Sodium 1,5-dioxo-1,5-dihydro-4h-pyrido[3,2-a]phenoxazine-3-carboxylate

35. Sodium 1-hydroxy-5-oxo-5h-pyrido(3,2-a)(phenoxazine-3-carboxylate

36. 5h-pyrido(3,2-a)phenoxazine-3-carboxylic Acid, 1-hydroxy-5-oxo-, Sodium Salt (1:1)

2.4 Create Date
2008-02-05
3 Chemical and Physical Properties
Molecular Weight 330.23 g/mol
Molecular Formula C16H7N2NaO5
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count7
Rotatable Bond Count1
Exact Mass330.02526561 g/mol
Monoisotopic Mass330.02526561 g/mol
Topological Polar Surface Area108 Ų
Heavy Atom Count24
Formal Charge0
Complexity777
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty